4
Changes in Ownership
IN8BIO, INC. Filed Acc 0001415889-25-012288
CHIEF FINANCIAL OFFICER acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCall Patrick CHIEF FINANCIAL OFFICER | 2025-04-30 | Option exercise | +15,000 | $0.18 | $2,766 | 67,071 | D |
| Derivatives | |||||||
| McCall Patrick CHIEF FINANCIAL OFFICER | 2025-04-27 | Returned to the company · Series A Warrants (right to buy) | −15,000 | 5,492 | D | ||
| McCall Patrick CHIEF FINANCIAL OFFICER | 2025-04-27 | Grant or award · Series A Warrants (right to buy) | +15,000 | 15,000 | D | ||
| McCall Patrick CHIEF FINANCIAL OFFICER | 2025-04-30 | Option exercise · Series A Warrants (right to buy) | −15,000 | 0 | D | ||
| McCall Patrick CHIEF FINANCIAL OFFICER | 2025-04-27 | Returned to the company · Series B Warrants (right to buy) | −20,492 | 0 | D | ||
| McCall Patrick CHIEF FINANCIAL OFFICER | 2025-04-27 | Grant or award · Series B Warrants (right to buy) | +20,492 | 20,492 | D | ||
Loading xslF345X05/form4-05072025_080505.xml…